Content
All Posts > Content under Healthcare
Overview Of Emerald Health Therapeutics, A Growing Cannabis Producer In Canada
Article By:
InvestInMJ
Read
Tuesday, September 19, 2017 9:00 AM EDT
As Canada moves towards legalization, next year should be an exciting time for investors in the cannabis industry. Here we look at Emerald Health Therapeutics, a licensed producer in Canada with interesting growth prospects.
Three Canadian Cannabis Updates To Start Your Week
Article By:
Technical420
Read
Monday, September 18, 2017 8:00 AM EDT
Canadian cannabis stocks have been trending higher over the last week.
Weighing The Week Ahead: Will A More Aggressive Fed Spark The Long-Awaited Correction?
Article By:
Jeff Miller
Read
Sunday, September 17, 2017 4:03 AM EDT
We have a light economic calendar. The housing data are important, but Wednesday’s FOMC decision and Chair Yellen’s press conference will take the spotlight. Other Fed participants will also hit the speaking trail after the meeting.
Week In Review: Shanghai United Imaging Raises $500 Million In Series A; Zai Lab Will IPO Next Week
Article By:
ChinaBio® Today
Read
Saturday, September 16, 2017 3:31 PM EDT
Shanghai United Imaging Healthcare's recent financing from large China investors is the largest medical device funding in China to date, and values Shanghai United at $5 billion.
AskSlim Market Week - Friday, Sept 15
Video By:
Steve Miller
Watch
Friday, September 15, 2017 10:36 PM EDT
The stock market moved up early in the week last week and basically went flat now with the S&P 500 hovering just below 2500 level.
In this video: D, AKS, APA, BZH, CHK, DVN, GPS, HUM, M, MCD, NBR, NE, RIG, TIF, CSIQ, FSLR, NVDA, ORCL, TSLA, ANTM
The Health Care Sector Is Breaking Out
Article By:
Chad Shoop
Read
Friday, September 15, 2017 12:25 PM EDT
Since the election, the health care exchange-traded fund has soared over 20%, outperforming the S&P 500 by 5 percentage points. This outperformance will have its ups and downs, but after the breakout last week, health care has more room to run.
In this article: XLV
4 Biotech Stocks That Show Promise On Sustainable Growth
Article By:
Zacks Investment Research
Read
Friday, September 15, 2017 7:20 AM EDT
Within the Medical sector, biotech stocks have performed well in the first half of the year, despite challenges like rising competition, pipeline setbacks, slowdown in growth of mature products and generic competition for certain key drugs.
Learning The ABCs
Article By:
Tim Knight
Read
Thursday, September 14, 2017 9:39 PM EDT
They say the hardest trade is the best trade…and the hardest trade to do these days is to short a stock. There hasn’t been even a 5% correction in the market for nearly two years now.
Biotech Momentum Eases: September Is A Bit Sluggish
Article By:
Rod Raynovich
Read
Thursday, September 14, 2017 6:08 PM EDT
Risks for biotech stocks and the healthcare sector, in general, are with Congress: drug pricing debate and/or lack of progress on tax reform.
In this article: BLUE, XLV, IBB, ABBV, XBI, HALO, PFE, CLLS, ARRY, RXDX, KITE, AGIO, CLVS, EXEL, INCY, JUNO, TSRO, PBYI
TGOD, The IPO That Has The Eyes And Ears Of The Entire Cannabis Industry
Article By:
Technical420
Read
Thursday, September 14, 2017 2:04 PM EDT
Today, TGOD announced its final pre-IPO non-brokered private placement at $1.65 per unit. This offering is slightly different from the prior two and in our eyes, it is just as attractive.
Epizyme Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Thursday, September 14, 2017 1:24 PM EDT
Epizyme, Inc., today announced the pricing of an underwritten public offering of 9,180,000 shares of its common stock at a price of $15.25 per share, before underwriting discounts.
In this article: EPZM
Lots More Than Aspirin: What You Should Know About Bayer
Article By:
Bram De Haas
Read
Thursday, September 14, 2017 1:13 PM EDT
German conglomerate Bayer can best be described as a pharma/medical business and it trades at a steep discount to peers. The conglomerate is attractive because it is not very expensive at 16x free cash flow.
In this article: BAYZF
Hot Options Report For End Of Day - Wednesday, September 13
Article By:
The Options Insider
Read
Wednesday, September 13, 2017 4:36 PM EDT
The most active equity options and strikes for end of the day Wednesday: AAPL, GILD and BAC.